Therapeutic aspects of growth hormone and insulin‐like growth factor‐I treatment on visceral fat and insulin sensitivity in adults
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Growth hormone (GH) is generally considered to exert anti‐insulin actions, whereas insulin‐like growth factor I (IGF‐I) has insulin‐like properties. Paradoxically, GH deficient adults and those with acromegaly are both predisposed to insulin resistance, but one cannot extrapolate from these pathological conditions to determine the normal metabolic roles of GH and IGF‐I on glucose homeostasis. High doses of GH treatment have major effects on lipolysis, which plays a crucial role in promoting its anti‐insulin effects, whereas IGF‐I acts as an insulin sensitizer that does not exert any direct effect on lipolysis or lipogenesis. Under physiological conditions, the insulin‐sensitizing effect of IGF‐I is only evident after feeding when the bioavailability of circulating IGF‐I is increased. In contrast, many studies in GH deficient adults have consistently shown that GH replacement improves the body composition profile although these studies differ considerably in terms of age, the presence or absence of multiple pituitary hormone deficiency, and whether GH deficiency was childhood or adult‐onset. However, the improvement in body composition does not necessarily translate into improvements in insulin sensitivity presumably due to the anti‐insulin effects of high doses of GH therapy. More recently, we have found that a very low dose GH therapy (0.1 mg/day) improved insulin sensitivity without affecting body composition in GH‐deficient adults and in subjects with metabolic syndrome, and we postulate that these effects are mediated by its ability to increase free ‘bioavailable’ IGF‐I without the induction of lipolysis. These results raise the possibility that this low GH dose may play a role in preventing the decline of β‐cell function and the development of type 2 diabetes in these “high risk” subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
Ho, K. Y., Veldhuis, J. D., Johnson, M. L., Furlanetto, R., Evans, W. S., Alberti, K. G., & Thorner, M. O. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113450 · Cited by 503
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1982) · Diabetes · doi:10.2337/diab.31.8.663 · Cited by 440
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369
Moses, A. C., Young, S. C., Morrow, L. A., O'Brien, M., & Clemmons, D. R. (1996) · Diabetes · doi:10.2337/diab.45.1.91 · Cited by 291
Growth hormone-deficient adults are insulin-resistant
Johansson, J.-O., Fowelin, J., Landin, K., Lager, I., & Bengtsson, B.-Å. (1995) · Metabolism · doi:10.1016/0026-0495(95)90004-7 · Cited by 275
Effects of a growth hormone pulse on total and forearm substrate fluxes in humans
Moller, N., Jorgensen, J. O., Schmitz, O., Moller, J., Christiansen, J., Alberti, K. G., & Orskov, H. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.1.e86 · Cited by 194
Thrailkill, K. M., Quattrin, T., Baker, L., Kuntze, J. E., Compton, P. G., & Martha, P. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.585 · Cited by 88
Accelerated ribosome formation and growth in neonatal pig hearts
Camacho, J. A., Peterson, C. J., White, G. J., & Morgan, H. E. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.1.c86 · Cited by 81
Cited by
Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice
Tomás-Loba, A., Flores, I., Fernández-Marcos, P. J., Cayuela, M. L., Maraver, A., Tejera, A., Borrás, C., Matheu, A., Klatt, P., Flores, J. M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.034 · Cited by 484
Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes
Clemmons, D. R. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.017 · Cited by 297
Insulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., De Ita, J. R., de la Garza, R. G., & Castilla-Cortazar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 295
Luque, R. M., Lin, Q., Córdoba-Chacón, J., Subbaiah, P. V., Buch, T., Waisman, A., Vankelecom, H., & Kineman, R. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015767 · Cited by 73
“Improved insulin signaling in the context of isolated GHD is consistent with the well accepted anti-insulin actions of GH following an acute bolus injection in normal and GHD adults [29], and as observed following chronic GH elevation in patients with GH producing pituitary tumors [30], as well as in mice overexpressi…”
Circulating levels of growth hormone in postural orthostatic tachycardia syndrome
Johansson, M., Ricci, F., Schulte, J., Persson, M., Melander, O., Sutton, R., Hamrefors, V., & Fedorowski, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-87983-5 · Cited by 9
Metadata
- Authors
- Yuen, K. C. J., & Dunger, D. B.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2006-04-20
- Volume
- 9
- Issue
- 1
- Pages
- 11-22
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2159169885
- Cited by
- 78
- References
- 9
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic aspects of growth hormone and insulin‐like growth factor‐I treatment on visceral fat and insulin sensitivity in adults. https://app.cochat.ai/papers/10.1111/j.1463-1326.2006.00591.x
- The paper
- Yuen, K. C. J., & Dunger, D. B. (2007). Therapeutic aspects of growth hormone and insulin‐like growth factor‐I treatment on visceral fat and insulin sensitivity in adults. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2006.00591.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.